| Literature DB >> 29428565 |
Shingen Nakamura1, Momoyo Azuma2, Tomoko Maruhashi3, Kimiko Sogabe3, Ryohei Sumitani3, Munenori Uemura3, Masami Iwasa3, Shiro Fujii3, Hirokazu Miki4, Kumiko Kagawa3, Takashi Hiraga5, Noriyasu Kondo5, Hiromi Fujita6, Fumihiko Mahara7, Masahiro Abe3.
Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by the SFTS virus (SFTSV). Clinical symptoms of SFTS often involve encephalopathy and other central neurological symptoms, particularly in seriously ill patients; however, pathogenesis of encephalopathy by SFTSV is largely unknown. Herein, we present case reports of three patients with SFTS, complicated by encephalopathy, admitted to Tokushima University hospital: one patient was a 63-year-old man, while the other two were 83- and 86-year-old women. All of them developed disturbance of consciousness around the 7th day post onset of fever. After methylprednisolone pulse therapy of 500 mg/day, all of them recovered without any neurological sequelae. SFTSV genome was not detected in the cerebrospinal fluid of 2 out of the 3 patients that were available for examination. In these patients, disturbance of consciousness seemed to be an indirect effect of the cytokine storm triggered by SFTSV infection. We propose that short-term glucocorticoid therapy might be beneficial in the treatment of encephalopathy during early phase of SFTSV infection.Entities:
Keywords: Encephalopathy; Severe fever with thrombocytopenia syndrome; Steroid pulse therapy
Mesh:
Substances:
Year: 2018 PMID: 29428565 DOI: 10.1016/j.jiac.2017.11.004
Source DB: PubMed Journal: J Infect Chemother ISSN: 1341-321X Impact factor: 2.211